AU Stock MarketDetailed Quotes
1AD AdAlta Ltd
- 0.029
- +0.001+3.57%
20min DelayMarket Closed May 2 16:00 AET
15.45MMarket Cap-1933P/E (Static)
0.029High0.028Low503.00KVolume0.028Open0.028Pre Close14.18KTurnover0.04852wk High0.26%Turnover Ratio532.62MShares0.01752wk Low-0.013EPS TTM5.61MFloat Cap0.378Historical HighLossP/E (Static)193.35MShs Float0.017Historical Low-0.015EPS LYR3.57%Amplitude--Dividend TTM5.80P/B1Lot Size--Div YieldTTM
About AdAlta Ltd Company
AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.
Company Profile
Symbol1AD
Company NameAdAlta Ltd
Founded2006
MarketASX
Employees10
Fiscal Year Ends06-30
Address2 Park Drive Unit 15
CityBundoora
CountryAustralia
Zip Code3083
Phone+61 394795159
Websitehttps://www.adalta.com.au
Company Executives
- Name
- Position
- Salary
- Timothy Oldham
- Managing Director,Chief Executive Officer
- --
- Paul MacLeman
- Executive Chairman,Executive Director
- --
- Robert Peach
- Non-Executive Director
- --
- David Fuller
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg